(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 16.85% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 12.91%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10%.
Progyny's revenue in 2024 is $1,108,282,000.On average, 3 Wall Street analysts forecast PGNY's revenue for 2024 to be $119,803,432,138, with the lowest PGNY revenue forecast at $118,016,520,707, and the highest PGNY revenue forecast at $123,320,313,029. On average, 5 Wall Street analysts forecast PGNY's revenue for 2025 to be $141,997,279,656, with the lowest PGNY revenue forecast at $129,928,628,776, and the highest PGNY revenue forecast at $151,267,584,957.
In 2026, PGNY is forecast to generate $169,295,908,257 in revenue, with the lowest revenue forecast at $155,762,001,430 and the highest revenue forecast at $178,110,296,904.